1. Home
  2. MCW vs AUPH Comparison

MCW vs AUPH Comparison

Compare MCW & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mister Car Wash Inc.

MCW

Mister Car Wash Inc.

HOLD

Current Price

$7.10

Market Cap

2.3B

Sector

N/A

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.29

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCW
AUPH
Founded
1996
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
MCW
AUPH
Price
$7.10
$15.29
Analyst Decision
Hold
Buy
Analyst Count
11
4
Target Price
$7.28
$17.25
AVG Volume (30 Days)
3.1M
1.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
47.62
5075.00
EPS
0.10
0.25
Revenue
$1,051,731,000.00
$283,055,000.00
Revenue This Year
$7.92
$17.54
Revenue Next Year
$7.05
$15.74
P/E Ratio
$70.89
$63.38
Revenue Growth
5.73
20.38
52 Week Low
$4.61
$7.29
52 Week High
$7.69
$16.88

Technical Indicators

Market Signals
Indicator
MCW
AUPH
Relative Strength Index (RSI) 65.28 45.49
Support Level $6.95 $14.53
Resistance Level $7.14 $16.38
Average True Range (ATR) 0.04 0.66
MACD -0.00 -0.06
Stochastic Oscillator 58.62 39.80

Price Performance

Historical Comparison
MCW
AUPH

About MCW Mister Car Wash Inc.

Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. The company's car wash locations consist of two formats: Express Exterior Locations and Interior Cleaning Locations. Express Exterior Locations offer self-drive exterior cleaning services and include free vacuums available for customer use. Interior Cleaning Locations offer exterior and interior cleaning services, including vacuuming. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: